Is Sunosi (solriamfetol) a controlled substance?
Medically reviewed by Drugs.com. Last updated on Aug 31, 2023.
Yes. Sunosi (solriamfetol) is a Schedule IV Controlled Substance in the United States.
Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). It was approved by the FDA in March 2019.
Sunosi is a federally controlled substance (CIV) because it contains solriamfetol, which has the potential for abuse.
Sunosi should always be stored in a safe place to protect it from theft. Any unused or expired Sunosi should be disposed of via a medication take-back program, or mixed with an undesirable substance and thrown away in the household trash.
Related medical questions
- Can you have narcolepsy and insomnia?
- What are the early signs of narcolepsy?
- What is the difference between narcolepsy and idiopathic hypersomnia?
- How do you test for narcolepsy?
- What is the treatment for narcolepsy?
- Modafinil vs Adderall: What's the difference?
- What exactly is Captagon and why was it banned?
- Focalin vs Adderall: What's the difference?
- Modafinil: Smart Drug For Decision Fatigue Or Workaholic Crutch?
- How long does Adderall withdrawal last?
- Ritalin vs Vyvanse - What's the difference between them?